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Research article Distal femoral bone mineral density decreases 
following patellofemoral arthroplasty: 1-year 
follow-up study of 14 patients
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Abstract
Background: The bone mineral density (BMD) of the distal femur decreases by 16-36% within one year after total knee 
arthroplasty (TKA) because of the femoral component's stress-shielding effect. The aim of this prospective study was to 
determine the quantitative change from the baseline BMD in the distal femur 1 year after patellofemoral arthroplasty 
using dual-energy X-ray absorptiometry (DXA).
Methods: Between December 2007 and December 2008, 14 patients had patellofemoral arthroplasty for isolated 
patellofemoral osteoarthritis. Distal femoral BMD was assessed using DXA in 2 regions of interest (ROI) on the lateral 
view 2 weeks before and 12 months after patellofemoral arthroplasty. The contra-lateral knee was used as a control, 
with BMD measurements performed in identical ROIs.
Results: The mean change from baseline BMD in the operated knees after 1 year was -0.169 g/cm2 (95% CI: -0.293 to -
0.046 g/cm2) behind the anterior flange (-15%), and -0.076 g/cm2 (95% CI: -0.177 to 0.024 g/cm2) in the supracondylar 
area 1 cm above the prosthesis (-8%) (p = 0.01 and p = 0.13, respectively). The mean change from baseline BMD in the 
non-operated knees after 1 year was 0.016 g/cm2 (95% CI: -0.152 to 0.185 g/cm2) behind the anterior flange (2%), and 
0.023 g/cm2 (95% CI: -0.135 to 0.180 g/cm2) in the supracondylar area 1 cm above the prosthesis (2%) (p = 0.83, and p = 
0.76, respectively).
Conclusions: Our findings suggest that patellofemoral arthroplasty results in a statistically significant decrease in BMD 
behind the anterior flange.
Background
After total knee arthroplasty (TKA), the bone mineral
density (BMD) of the distal femur decreases by 16-36%
within one year because of the femoral component's
stress-shielding effect [1-7]. Although the femoral com-
ponent in patellofemoral arthroplasty is smaller than in
TKA, the mechanical loading, and consequently the
stress distribution of the distal femoral bone, is altered
compared with the physiological situation. This can lead
to bone remodeling, resulting in decreased BMD behind
the anterior flange of the femoral component. In TKA,
bone loss in the distal anterior femur can lead to supra-
condylar fractures or loosening of the implant, and may
induce difficulties during revision arthroplasty [8,9].
Since patellofemoral arthroplasty is typically used in
younger patients, conversion to TKA after painful femo-
r o t i b i a l  o s t e o a r t h r i t i s  d e v e l o p s  w i l l  e v e n t u a l l y  b e  p e r -
formed in a relatively large proportion of patients [10].
Although the clinical outcome of TKA done later does
not appear to be influenced by prior patellofemoral
arthroplasty [11], the results of such a revision may, how-
ever, be compromised by loss of bone stock.
To date, no clinical studies have addressed the possible
decrease in distal femoral BMD as a parameter of bone
remodeling following patellofemoral arthroplasty. We
hypothesized that because of the relative small size there
is no significant stress-shielding effect behind the femoral
component of a patellofemoral prosthesis resulting in a
decrease in BMD in the distal femur. The primary objec-
tive was, therefore, to determine the change from base-
line in the BMD behind the anterior flange 1 year after
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patellofemoral arthroplasty using dual-energy X-ray
absorptiometry (DXA).
Methods
In 2007, we initiated a prospective study to investigate the
distal femoral BMD using DXA in patients undergoing
patellofemoral arthroplasty. All patients who were
planned for patellofemoral arthroplasty for isolated patel-
lofemoral osteoarthritis at Deventer Hospital, Deventer,
The Netherlands, were evaluated for inclusion in the
study. Patients with known rheumatic, renal, hepatic, or
gastrointestinal disease, and patients using medication
that interferes with mineral metabolism (i.e. treatment
for osteoporosis or long-term steroid therapy) were
excluded from the study. Additionally, patients with a
previous TKA or patellofemoral arthroplasty of the con-
tra-lateral knee were excluded. The study was approved
by the Regional Ethics Committee (NL16145.075.07,
December 2007) and Institutional Review Board.
Sample size was calculated using estimates of mean
femoral BMD and standard deviation (SD) behind the
anterior flange after TKA [1]. The reported mean BMD
behind the anterior flange of a total knee prosthesis in the
replaced knee was 0.94 g/cm2  (0.31), and 1.25 g/cm2
(0.30) in the contra-lateral, non-replaced knee [1]. A
group sample size of 13 patients achieves 95% power to
detect a difference of 0.31 g/cm2  between the null
hypothesis that both group means are 1.25 g/cm2, and the
alternative hypothesis that the mean of group 2 (replaced
knee) is 0.94 g/cm2 with known group SDs of 0.31 g/cm2
and 0.30 g/cm2 and with a significance level (alpha) of
0.05 using a two-tailed paired t-test (PASS 2008, NCSS
software, Kaysville, Utah).
Between December 2007 and December 2008, 2 ortho-
pedic surgeons who performed patellofemoral arthro-
plasty at Deventer Hospital recruited 14 patients. All
patients provided written informed consent. All eligible
patients were preoperatively assessed by 1 of the 2 partic-
ipating orthopedic surgeons, who completed the Knee
Society Knee Score (KSKS) and the Knee Society Func-
tional Score (KSFS). The Dutch version of the Western
Ontario and McMaster Universities Osteoarthritis Index
3.1 (WOMAC) was completed by all patients. Measure-
ment of the BMD in the distal femur was performed
using DXA in the lateral view (GE Lunar Prodigy system,
General Electrics, Oldelft Benelux B.V., Delft/
Veenendaal, The Netherlands) 2 weeks before patell-
ofemoral arthroplasty and 12 months after arthroplasty.
Measurements of a calibration phantom were performed
each day before scanning the patients. All measurements
were made by an independent radiographic technician.
Both the scanning procedure and positioning of the
patients and knees were standardized, with the patient in
the lateral decubitus position and the knee flexed 15-30
degrees to obtain a true lateral scan. Two regions of inter-
est (ROI) were selected; one in the distal anterior area just
behind the anterior flange of the prosthesis (centered
between the tip of the fixation peg and the proximal end
of the prosthesis) (ROI 1), and the other more proximally,
in the supracondylar area 1 cm superior to the anterior
flange of the femoral component (ROI 2) (Figure 1). ROI
2 was selected as a reference ROI above the prosthesis,
where stress-shielding was assumed to be negligible. The
measured area of each ROI was 1 × 1 cm. The contra-lat-
eral, non-operated knee was used as a control, with BMD
measurements in identical ROIs. We employed knee-spe-
cific software in all cases.
Two similarly experienced surgeons at our institution
performed patellofemoral arthroplasty with the currently
commercially available Richards type II prosthesis (Smith
& Nephew Inc., Memphis, Tennessee). Surgery was per-
formed under pneumatic tourniquet control and antibi-
Figure 1 Location of regions of interest (ROI) on a lateral radio-
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otic prophylaxis using intravenous Cefazoline 1 g, 3 times
daily, for the first 24 hours with the first dose adminis-
tered 30 minutes before application of the tourniquet. All
operations were performed in an identical manner
according to the manufacturers' instruction, as described
elsewhere [10]. No intramedullary guiding rod was used
during surgery. All 14 patients received the same postop-
erative treatment. We allowed patients protected weight
bearing with crutches immediate after surgery, and full
unrestricted weight bearing was allowed 6 weeks after
surgery. All patients routinely received antithrombotic
prophylaxis with a low-molecular-weight heparin (Frag-
min) for 6 weeks.
All patients had regular clinical follow-ups at 2 and 8
weeks to evaluate wound healing and rehabilitation, DXA
was not performed at these follow-up visits. At the 1-year
follow-up, patients were clinically assessed using the
KSKS and KSFS, and were asked to complete the
WOMAC questionnaire. During follow-up, the radiologi-
cal examinations consisted of 2 radiographs (anteroposte-
rior standing and lateral non-weight bearing) performed
6 weeks and one year post surgery (Figure 2). Radiological
findings were reported using the Knee Society total knee
arthroplasty roentgenographic evaluation and scoring
system [12].
All pertinent data were entered in a spreadsheet pro-
gram and analyzed using PASW Statistics 18 software
(SPSS Inc, Chicago, Illinois). We performed descriptive
analysis using the mean and standard deviation for con-
tinuous variables, and frequencies for categorical vari-
ables. The 95% confidence intervals (CI) were calculated
for the absolute changes in BMD from baseline. The two-
tailed paired t-test was used to analyze for differences in
preoperative and postoperative BMD. A linear regression
model was used to evaluate for influence of BMI, age, and
sex on change in BMD from baseline. A p-value of less
than 0.05 was considered significant in all the tests.
Results
Between December 2007 and December 2008, 14 patients
had unilateral patellofemoral arthroplasty, receiving the
Richards type II patellofemoral prosthesis. All 14 patients
were available for the one year follow-up. The patient's
demographic data are presented in Table 1.
Mean KSKS improved from 61 (range, 50 to 78) preop-
eratively to 88 (range, 60 to 100) one year after surgery (p
< 0.001). Mean KSFS improved from 65 (range, 50 to 80)
preoperatively to 86 (range, 50 to 100) one year after sur-
gery (p = 0.004). The mean preoperative WOMAC scores
improved from 50 (range, 22 to 69) to 23 (range, 4 to 39)
one year after surgery (p < 0.001). No complications were
noted from the surgical procedure within the study
period. The 1-year radiographic follow-up showed that
all prostheses were in good alignment without radiolu-
cent lines or osteolysis.
Results of the BMD measurements are summarized in
Table 2. In the operated knees, there was a 15% decrease
in mean BMD at 12 months in ROI 1 (p = 0.01), and an
8% decrease in ROI 2 (p = 0.13). In the non-operated
knees, there was a 2% increase in the mean BMD at 12
months in both ROI 1 and ROI 2 (p = 0.83 and p = 0.76,
respectively).
Regression analysis of the change from baseline BMD
for both regions of interest against BMI (regression coef-
ficient = 0.017, p = 0.3), age (regression coefficient =
0.002, p = 0.8), and sex (regression coefficient = -0.063, p
= 0.6) demonstrated no significant relationships.
Discussion
The results of our prospective, 1-year DXA study demon-
strate a statistically significant 15% decrease in BMD
behind the anterior flange of the femoral component dur-
ing the first year after patellofemoral arthroplasty. To our
knowledge, there has been no previous study that
Table 1: Patient characteristics.
Characteristic
Number of knees 14
Side (right: left) 7 : 7
Mean (SD) age at surgery 53 (10) years
Sex (female: male) 9 : 5
Mean (SD) Height 175 (5) cm
Mean (SD) Weight 87 (13) kg
Mean (SD) body mass index 28 (4) kg/m2
Continuous values are given as the mean with standard deviation 
in parentheses.
Figure 2 Lateral (left) and anteroposterior (right) radiographs of 
a right knee one year after patellofemoral arthroplasty.van Jonbergen et al. BMC Musculoskeletal Disorders 2010, 11:74
http://www.biomedcentral.com/1471-2474/11/74
Page 4 of 5
attempted to use DXA measurements to evaluate changes
in the distal femoral BMD after patellofemoral arthro-
plasty. Several investigators reported the results of BMD
measurements after TKA and demonstrated peripros-
thetic bone loss of up to 36% adjacent to the implants [1-
7]. The general BMD as measured in hip and spine, or the
BMD in the contra-lateral knee, did not change after
arthroplasty [1-3,7].
Finite-element models were used to determine whether
patterns of bone resorption behind the femoral compo-
nent in TKA could be explained by strain-adaptive bone
remodeling [13,14]. With a bonded femoral component,
the predicted long-term bone loss would occur at the
most distal part of the femur and behind the anterior part
of the prosthesis [13]. These findings are in agreement
with the results of clinical DXA studies, which observed
loss of BMD behind the anterior flange of the femoral
component in TKA [1-7]. Our results show that compa-
rable distal femoral bone loss occurs following patell-
ofemoral arthroplasty. This suggests that the stress-
shielding effect is similar to that which occurs after TKA,
even with the smaller femoral component of the patell-
ofemoral prosthesis (Figure 2). However, the clinical
results do not seem to be compromised by the observed
loss of bone. In a recent study, the long-term outcomes of
the Richards type II patellofemoral arthroplasty were
reported [10]. The most common reasons for conversion
in this series were progression of femorotibial osteoar-
thritis and revision for malpositioning that resulted in
catching and instability. Loosening of the femoral compo-
nent was not observed, which is in accordance with the
literature. Furthermore, the clinical outcome of later
TKA does not appear to be influenced by prior patell-
ofemoral arthroplasty [11,15]. No technical difficulties
were experienced during conversion, and the condylar
support in each knee was uncompromised.
The observed decrease in the BMD in the supracondy-
lar reference ROI 2 was not statistically significant. Other
investigators demonstrated an 8% decrease in the BMD in
this diaphyseal ROI at 1 year after total knee arthroplasty
[5,7]. Soininvaara et al. suggested that this less pro-
nounced bone loss represented both operation-related
and postoperative immobilization-induced bone loss,
because age-related bone loss is minor [5]. However,
physical activity had improved in our patients, as demon-
strated by the improvement in KSFS and WOMAC
scores.
The current study has some limitations that should be
noted. Follow-up examinations were performed at 1 year
after surgery. With TKA, several investigators report that
no additional remodeling occurs after 6-12 months [2,5-
7], while others stated that loss of BMD stabilizes within 2
years [1,16]. Finite element models predict that bone
resorption may continue after 2 years [13]. Thus, it is pos-
sible that a further decrease in BMD occurs in our
patients. Another limitation is that we performed no pre-
cision measurements in our relatively small series. There-
fore, we assumed a precision similar to those reported by
others using the same Lunar Prodigy system, albeit with
possible software differences. The reported precision for
BMD measurements on the lateral view of the anterior
femur ranges from 1.3% to 3.6% [3,4,7,17,18]. Because of
the relatively small size of the patellofemoral prosthesis,
the ROI behind the anterior flange was also necessarily
small, which may have resulted in weakened precision
[17].
Although our study protocol excluded medical condi-
tions that could have affected the BMD, it is possible that
other conditions may have existed that influenced the
results. None of the patients had a severe medical disabil-
ity that limited the ability to walk, or had a disabling dis-
ease involving other joints of the lower extremities. We
Table 2: Bone mineral density (BMD, g/cm2) measured in the distal femur before (t = 0) and 12 months after (t = 12) 
patellofemoral arthroplasty.
BMD (t = 0) BMD (t = 12) Change from 
baseline
95% CI for the 
difference
p-value
Operated knee
ROI 1 1.106 (0.229) 0.937 (0.362) -0.169 (0.204) -0.293 to -0.046 0.01
ROI 2 0.981 (0.272) 0.905 (0.261) -0.076 (0.167) -0.177 to 0.024 0.13
Non-operated 
knee
ROI 1 1.099 (0.266) 1.115 (0.315) 0.016 (0.251) -0.152 to 0.185 0.83
ROI 2 0.930 (0.175) 0.952 (0.266) 0.023 (0.234) -0.135 to 0.180 0.76
Continuous values are given as the mean with standard deviation in parentheses.
CI, confidence interval; ROI, region of interest.van Jonbergen et al. BMC Musculoskeletal Disorders 2010, 11:74
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did not assess the amount of physical activity at one-year
follow-up and were therefore not able to evaluate for a
relationship with change from baseline BMD.
Conclusions
Our findings suggest that Richards type II patellofemoral
arthroplasty results in a statistically significant decrease
in BMD behind the anterior flange. Newer designs, such
as the Journey patellofemoral prosthesis (Smith &
Nephew) and the Zimmer Gender Solutions PFJ system,
employ a broader trochlear component. In theory, the
geometry, size, and material properties may result in dif-
ferent patterns of stress shielding. Future studies should
be aimed at evaluating BMD changes in these newer
patellofemoral prostheses.
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